RT Journal Article SR Electronic T1 A COMPARISON OF THE ADRENERGIC RECEPTOR BLOCKING PROPERTIES OF 1-(4'-METHYLPHENYL)-2-ISOPROPYLAMINO-PROPANOL-HCl AND PROPRANOLOL JF Journal of Pharmacology and Experimental Therapeutics JO J Pharmacol Exp Ther FD American Society for Pharmacology and Experimental Therapeutics SP 452 OP 462 VO 156 IS 3 A1 Bernard Levy YR 1967 UL http://jpet.aspetjournals.org/content/156/3/452.abstract AB The effects of 1-(4'-methylphenyl)-2-isopropylamino-propanol-HCl (H 35-25) treatment on a number of adrenergic responses to isoproterenol were determined in the anesthetized dog and the isolated rat uterus. H 35-25 was compared, quantitatively, to propranolol in the anesthetized dog studies. Studies in the dog included the effects of treatment with H 35-25 and propranolol, in a dose range of 0.1 to 3.0 mg/kg, upon the positive inotropic, positive chronotropic, vasodilator, blood pressure and intestinal inhibitory responses to isoproterenol. Studies with the isolated, spontaneously contracting rat uterus consisted of a determination of both the intrinsic action of H 35-25 and its ability to modify the rat uterine inhibitory response to isoproterenol. Propranolol blocked all of the responses to isoproterenol in the anesthetized dog, simultaneously, in the same dose range (0.1-1.0 mg/kg). H 35-25 produced a blockade of the vasodilator and blood pressure responses to isoproterenol in a dose range of 0.3 to 1.0 mg/kg but did not block the positive inotropic, positive chronotropic or intestinal inhibitory responses to isoproterenol. In the rat uterus, H 35-25 produced an intrinsic inhibitory response which was abolished by propranolol. H 35-25 was also capable of blocking the rat uterine inhibitory response to isoproterenol. H 35-25 appears to be capable of producing a selective blockade of vascular beta receptors in a dose range that has little blocking action on cardiac beta receptors. © 1967 by The Williams & Wilkins Company